Screening-detected breast carcinoma in a patient with Cowden syndrome

Breast

Volumn 13, Issue 3, 2004, Pages 239-241

  Bau M G ^a   Arisio, R ^a   Cristini, G ^a   Bertone, E ^a   Campogrande, M ^a  

^a Anna   (Italy)

Author keywords

Breast cancer; Cowden syndrome; Diagnosis; Familial breast cancer; Mammographic screening; PTEN

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TAMOXIFEN;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CANCER GRADING; CANCER RISK; CANCER SCREENING; CASE REPORT; COWDEN SYNDROME; CYTOLOGY; ECHOMAMMOGRAPHY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAMMOGRAPHY; MOLECULAR MECHANICS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

EID: 3142659534     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00168-1     Document Type: Article

References (13)

1. Eng C. Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis Ann NY Acad Sci 968 2002 213-221
2. Starink T.M. van der Veen J.P. Arwert F. et al. The Cowden syndrome: a clinical and genetic study in 21 patients Clin Genet 29 1986 222- 233
3. Hanssen A.M.N. Fryns J.P. Cowden syndrome J Med Genet 32 1995 117-119
4. Longy M. Lacombe D. Cowden disease Report of a family and review. Ann Genet 39 1996 35-42
5. Eng C. Cowden syndrome J Genet Counsel 6 1997 181-191
6. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria J Med Genet 37 2000 828-830
7. NCCN NCCN practice guidelines: genetics/familial high risk cancer Oncology 13 1999 161-186
8. Stambolic V. Suzuki A. de la Pompa J.L. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 1-20
9. Depowski P.L. Rosenthal S.I. Ross J.S. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer Mod Pathol 14 2001 672-676
10. Bose S. Crane A. Hibshoosh H. et al. Reduced expression of PTEN correlates with breast cancer progression Hum Pathol 33 2002 405-409
11. Lakhani S.R. Van de Vijver M.J. Jacquemier J. et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2002 2310-2318
12. Mutter G.L. Lin M.C. Fitzgerald J.T. et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers J Natl Cancer Inst 92 2000 924-931
13. Mutter G.L. Lin M.C. Fitzgerald J.T. Changes in endometrial PTEN expression throughout the human menstrual cycle J Clin Endocrinol Metabol 85 2000 2334-2338